stating that they are a different gender rather than wish to be a different gender).Professionals who treat gender dysphoria in children sometimes prescribe puberty blockers to delay the onset of puberty until a child is believed to be old enough to make an informed decision on whether hormonal or surgical gender reassignment is in their best interest.A review published in Child and Adolescent Mental Health found that puberty blockers are fully reversible, and that they are associated with such positive outcomes as decreased suicidality in adulthood, improved affect and psychological functioning, and improved social life.A review commissioned by the UK Department of Health found that there was very low certainty of quality of evidence about puberty blocker outcomes in terms of mental health, quality of life and impact on gender dysphoria. The Finnish government commissioned a review of the research evidence for treatment of minors and the Finnish Ministry of Health concluded that there are no research-based health care methods for minors with gender dysphoria. Nevertheless, they recommend the use of puberty blockers for minors on a case-by-case basis, and the American Academy of Pediatrics state that "pubertal suppression in children who identify as TGD [transgender and gender diverse] generally leads to improved psychological functioning in adolescence and young adulthood. ".In the United States, several states have introduced or are considering legislation that would prohibit the use of puberty blockers in the treatment of transgender children.
Pegylated interferon and ribavirin are useful in reducing viral load. See also
Diffuse proliferative nephritis

References
External links

Glomerulonephritis, Membranoproliferative Types I, II, III at eMedicine
Corchado, Johnny Cruz, Smith, Richard JH (July 2007). "Dense Deposit Disease/Membranoproliferative Glomerulonephritis Type II". In Pagon RA, Bird TD, Dolan CR,  et al. (eds.). GeneReviews. Seattle WA: University of Washington. PMID 20301598. Membranoproliferative_GN at Nephropathology tutorial
MP GN Pathophysiology discusses the nephritic auto-antibodies/factors